Outbreak of Fungal Endophthalmitis Due to Fusarium oxysporum Following Cataract Surgery

Mycopathologia

Volumn 177, Issue 1-2, 2014, Pages 115-121

  Buchta, Vladimír ^a   Feuermannová, Alena ^a   Váša, Martin ^b   Bašková, Lenka ^c   Kutová, Radka ^a   Kubátová, Alena ^d   Vejsová, Marcela ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b Visus Eye Clinic   (Czech Republic)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Epidemiology; Exogenous endophthalmitis; Fusarium oxysporum; Outbreak; Treatment

Indexed keywords

FUSARIUM; FUSARIUM OXYSPORUM;

ANTIFUNGAL AGENT; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

AGED; ARTICLE; CATARACT EXTRACTION; ENDOPHTHALMITIS; EPIDEMIC; FEMALE; FUNGAL EYE INFECTION; FUSARIOSIS; FUSARIUM; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; POSTOPERATIVE COMPLICATION; VERY ELDERLY; VITRECTOMY;

AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CATARACT EXTRACTION; DISEASE OUTBREAKS; ENDOPHTHALMITIS; EYE INFECTIONS, FUNGAL; FEMALE; FUSARIOSIS; FUSARIUM; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PYRIMIDINES; TRIAZOLES; VITRECTOMY;

EID: 84893780324     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-013-9721-5     Document Type: Article

References (43)

1. Thomas PA. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev. 2003;16: 730-97.
2. Klotz SA, Penn CC, Negvesky GJ, Butrus SI. Fungal and parasitic infections of the eye. Clin Microbiol Rev. 2000;13: 662-85.
3. Schwartz SG, Flynn HW Jr, Scott IU. Endophthalmitis: classification and current management. Expert Rev Ophthalmol. 2007;2: 385-96.
4. Kernt M, Kampik A. Endophthalmitis: pathogenesis, clinical presentation, management, and perspectives. Clin Ophthalmol. 2010;24: 21-35.
5. Wykoff CC, Flynn HW Jr, Miller D, Scott IU, Alfonso EC. Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology. 2008;115: 1501-7 1507. e1-2.
6. Landlinger C, Bašková L, Preuner S, Willinger B, Buchta V, Lion T. Identification of fungal species by fragment length analysis of the internally transcribed spacer 2 region. Eur J Clin Microbiol Infect Dis. 2009;28: 613-22.
7. Gupta A, Srinivasan R, Kaliaperumal S, Saha I. Post-traumatic fungal endophthalmitis-a prospective study. Eye (Lond). 2008;22: 13-7.
8. Dursun D, Fernandez V, Miller D, Alfonso EC. Advanced Fusarium keratitis progressing to endophthalmitis. Cornea. 2003;22: 300-3.
9. Edelstein SL, Akduman L, Durham BH, Fothergill AW, Hsu HY. Resistant Fusarium keratitis progressing to endophthalmitis. Eye Contact Lens. 2012;38: 331-5.
10. Ferrer C, Alio J, Rodriguez A, Andreu M, Colom F. Endophthalmitis caused by Fusarium proliferatum. J Clin Microbiol. 2005;43: 5372-5.
11. Cakir M, Imamoǧlu S, Cekiç O, et al. An outbreak of early-onset endophthalmitis caused by Fusarium species following cataract surgery. Curr Eye Res. 2009;34: 988-95.
12. Güngel H, Eren MH, Pi{dotless}narci{dotless} EY, et al. An outbreak of Fusarium solani endophthalmitis after cataract surgery in an eye training and research hospital in Istanbul. Mycoses. 2011;54: e767-74.
13. Pettit TH, Olson RJ, Foos RY, Martin WJ. Fungal endophthalmitis following intraocular lens implantation. A surgical epidemic. Arch Ophthalmol. 1980;98: 1025-39.
14. Narang S, Gupta A, Gupta V, et al. Fungal endophthalmitis following cataract surgery: clinical presentation, microbiological spectrum, and outcome. Am J Ophthalmol. 2001;132: 609-17.
15. Magan N. Mycotoxin contamination of food in Europe: early detection and prevention strategies. Mycopathologia. 2006;162: 245-53.
16. Schollenberger M, Müller HM, Rüfle M, Suchy S, Plank S, Drochner W. Natural occurrence of 16 fusarium toxins in grains and feedstuffs of plant origin from Germany. Mycopathologia. 2006;161: 43-52.
17. Krčméry V Jr, Jesenská Z, Špánik S, et al. Fungaemia due to Fusarium spp. in cancer patients. J Hosp Infect. 1997;36: 223-8.
18. Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007;20: 695-704.
19. Chander J, Singla N, Gulati N, Sood S. Fusarium sacchari: a cause of exogenous fungal endophthalmitis: first case report and review of literature. Mycopathologia. 2011;171: 431-4.
20. Khan S, Pillai GS, Vivek V, Dinesh K, Karim PM. Post-operative endophthalmitis due to Fusarium dimerum. Southeast Asian J Trop Med Public Health. 2012;43: 1484-8.
21. Čechová M, Halasová A, Jesenská Z. Endophthalmitis caused by the microscopic fungus Fusarium solani [in Czech]. Čes a slov Oftal. 1988;44: 362-8.
22. Patel A, Hammersmith K. Contact lens-related microbial keratitis: recent outbreaks. Curr Opin Ophthalmol. 2008;19: 302-6.
23. Tabbara KF, al Jabarti AL. Hospital construction-associated outbreak of ocular aspergillosis after cataract surgery. Ophthalmology. 1998;105: 522-6.
24. Okhravi N, Adamson P, Lightman S. Use of PCR in endophthalmitis. Ocul Immunol Inflamm. 2000;8: 189-200.
25. Oechsler RA, Feilmeier MR, Ledee DR, et al. Utility of molecular sequence analysis of the ITS rRNA region for identification of Fusarium spp. from ocular sources. Invest Ophthalmol Vis Sci. 2009;50: 2230-6.
26. Marinach-Patrice C, Lethuillier A, Marly A, et al. Use of mass spectrometry to identify clinical Fusarium isolates. Clin Microbiol Infect. 2009;15: 634-42.
27. Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol. 2008;92: 871-8.
28. Troke P, Obenga G, Gaujoux T, et al. The efficacy of voriconazole in 24 ocular Fusarium infections. Infection. 2013;41: 15-20.
29. Marangon FB, Miller D, Giaconi JA, Alfonso EC. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol. 2004;137: 820-5.
30. Giaconi JA, Marangon FB, Miller D, Alfonso EC. Voriconazole and fungal keratitis: a report of two treatment failures. J Ocul Pharmacol Ther. 2006;22: 437-9.
31. Azor M, Gené J, Cano J, Manikandan P, Venkatapathy N, Guarro J. Less-frequent Fusarium species of clinical interest: correlation between morphological and molecular identification and antifungal susceptibility. J Clin Microbiol. 2009;47: 1463-8.
32. Espinel-Ingroff A, Cuenca-Estrella M, Fothergill A, et al. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Antimicrob Agents Chemother. 2011;55: 5150-4.
33. Lalitha P, Shapiro BL, Srinivasan M, et al. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Arch Ophthalmol. 2007;125: 789-93.
34. Spriet I, Delaere L, Lagrou K, Peetermans WE, Maertens J, Willems L. Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis. J Antimicrob Chemother. 2009;64: 877-8.
35. Mikus G, Scholz IM, Weiss J. Pharmacogenomics of the triazole antifungal agent voriconazole. Pharmacogenomics. 2011;12: 861-72.
36. Iqbal NJ, Boey A, Park BJ, Brandt ME. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E-test methods. Diagn Microbiol Infect Dis. 2008;62: 348-50.
37. Taylan Sekeroglu H, Erdem E, Yagmur M, Gumral R, Ersoz R, Ilkit M, Harbiyeli II. Successful medical management of recalcitrant Fusarium solani keratitis: molecular identification and susceptibility patterns. Mycopathologia. 2012;174: 233-7.
38. Oechsler RA, Feilmeier MR, Miller D, Shi W, Hofling-Lima AL, Alfonso EC. Fusarium keratitis: genotyping, in vitro susceptibility and clinical outcomes. Cornea. 2013;32: 667-73.
39. Espinel-Ingroff A, Johnson E, Hockey H, Troke P. Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies. J Antimicrob Chemother. 2008;61: 616-20.
40. Durand ML, Kim IK, D'Amico DJ, et al. Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin. Am J Ophthalmol. 2005;140: 552-4.
41. Sponsel WE, Graybill JR, Nevarez HL, Dang D. Ocular and systemic posaconazole (SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis. Br J Ophthalmol. 2002;86: 829-30.
42. Tu EY, McCartney DL, Beatty EF, Springer KL, Levy J, Edward D. Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592). Am J Ophthalmol. 2007;143: 222-7.
43. Thompson GR III, Wiederhold NP. Isavuconazole: a comprehensive review of spectrum of activity of a new triazole. Mycopathologia. 2010;170: 291-313.